semaglutide getting banned Ozempic Knock-Offs Contain Unsafe Substance by FDA, Novo Finds Belgium bans use of Ozempic

Lillys Foundayo (orforglipron) a non peptide based GLP-1 targeting pill launched earlier this month for treating obesity, has completed clinical evaluation over type-2 diabetes indication and the company is planning to seek approval under the FDAs priority review program

Scientists studied more than 1,000 foods, assigning each a nutritional score

This trend, observed in the USA and at least eight other high-income countries, starkly contrasts with the declining incidence rates of late-onset CRC (age 50 years and above), largely attributed to early disease detection and lifestyle changes

PlexusDx provides semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan from accredited 503A facilities, with no insurance needed and HSA/FSA eligibility